However, since iron regulation is a closed system lacking an active excretory channel and predominantly controlled by hepcidin, chronic IV iron therapies may pose a risk of iatrogenic iron overload, as reported in a chemotherapeutically treated 56‐year‐old breast cancer patient diagnosed with ESRD.115, 116. The gene discussed is HAMP; the disease is Tangier disease.